SURVENTA 4 ML Product Specifications
-
Administer intratracheally under physician supervision; dosage may depend on patient weight and condition
-
Premature infants at risk of or suffering from RDS
-
1 vial per box
-
To prevent and treat Respiratory Distress Syndrome (RDS) in premature infants
-
1 vial (4 mL)
-
Liquid
-
Respiratory Medication
-
Synthetic
-
Protein-rich synthetic surfactant
-
Synthetic peptides with phospholipids
-
Store between 2C to 8C (refrigerated); avoid freezing
-
Neonatal care
-
4 mL per administration
Other Products in 'Pharmaceutical Drugs' category
"We mainly export our products to the foreign countries."
&
We are accepting bulk order quantity.